International
Dragon Pharma MOTS-c 10 mg - Mitochondrial Peptide Vial
Injection · 10 mg · vial
Dragon Pharma MOTS-c is a 16 amino acid mitochondrial-derived peptide supplied as a 10 mg lyophilized vial for research use. It is studied for metabolic homeostasis and glucose handling in skeletal muscle, and its plasma level rises after physical activity.
GMP-manufactured and HPLC-verified, each batch carries a Certificate of Analysis (COA). MOTS-c 10 mg for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma MOTS-c 10 mg Mitochondrial Peptide Vial
Dragon Pharma MOTS-c is a mitochondrial-derived research peptide supplied as a single 10 mg lyophilized vial. MOTS-c is a 16 amino acid peptide coded inside the mitochondrial 12S rRNA region (MT-RNR1), so it is a signal the mitochondria send out rather than a classic hormone. Research interest centres on metabolic homeostasis and on how skeletal muscle handles glucose, and circulating MOTS-c rises in response to exercise in the published work.
- 10 mg lyophilized powder in a single vial - injection route, research use
- 16 amino acid mitochondrial-derived peptide coded in MT-RNR1
- GMP-manufactured and HPLC-verified - COA on file per batch
- U.S. domestic and international shipping on every order
How MOTS-c Works
MOTS-c is studied as a metabolic modulator: experimental work links it to AMPK signalling and to glucose uptake in muscle, which is the pathway behind the "exercise mimetic" label used in vendor material. The honest boundary is that most of the data comes from mouse models and from observational measurements of the peptide in plasma; human interventional data on MOTS-c itself are close to absent. The peptide is prohibited in sport at all times by WADA under class S4.4 (metabolic modulators). The same AMPK axis is studied on the AICAR page, and the mitochondria-targeting side of the shelf sits next to SS-31.
Reconstitution & Storage
MOTS-c arrives lyophilized and is dissolved with bacteriostatic water added against the vial wall, without shaking. A 10 mg vial in 2 ml gives 5 mg/ml, where 1 mg equals 0.2 ml or 20 units on a U-100 syringe. Vendor protocol reviews mention 5-10 mg two to three times a week in blocks of 4 to 8 weeks; those amounts are practice, not clinical evidence. Store the powder at 2-8 C away from light and use a reconstituted solution within about 28 to 30 days without freezing. Bacteriostatic water is the standard diluent for this shelf.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis kept for the batch. Keep the vial upright at 2-8 C, protect it from light and avoid repeated freeze-thaw cycles. The Axiolabs presentation of the same peptide is described on the MOTS-c Axiolabs page if you are comparing formats.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | MOTS-c |
| Generic Name | Mitochondrial-derived peptide (MT-RNR1) |
| Manufacturer | Dragon Pharma |
| Dosage | 10 mg per vial |
| Package | 1 lyophilized vial |
| Drug Class | Research peptide, metabolic modulator |
| Half-Life | Not established in humans |
| Administration | Subcutaneous after reconstitution |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
Research compounds only. Consult a healthcare professional before any use. Amounts shown are vendor protocol ranges, not clinical doses.
FAQ
Before you ask
Questions, answered
MOTS-c is a mitochondrial-derived peptide of 16 amino acids that is studied as a metabolic signal. Laboratory work links it to AMPK signalling and to glucose handling in skeletal muscle, and plasma levels of the peptide rise after exercise. The vial sold here is a research presentation: there is no approved human indication and no established human dose, so the material belongs in a laboratory context, not in a self-treatment plan.
Add bacteriostatic water against the wall of the vial and swirl gently, without shaking, so the peptide does not foam. A 10 mg vial with 2 ml of diluent gives 5 mg/ml, and 1 ml of diluent gives 10 mg/ml; on a U-100 syringe 1 mg equals 20 units in the first case and 10 units in the second. Keep the reconstituted solution at 2-8 C and use it within about 28 to 30 days.
Yes. MOTS-c is banned at all times under WADA class S4.4, the metabolic modulators group, and a therapeutic use exemption is described in the project files as very unlikely. Anyone subject to testing should treat the compound as prohibited rather than assume the research status changes anything.
There is no clinical safety dataset for the peptide. User reports collected in the fact sheet mention a faster heartbeat, injection site redness and irritation, and occasional trouble sleeping, with the suggestion to move the injection to the first half of the day. None of that is confirmed by trials. Because human safety data are thin, short blocks with breaks and careful self-observation are the honest approach.
Store the lyophilized vial at 2-8 C, protected from light, and keep it dry; a freezer is the vendor convention for long-term storage of the powder. Do not refreeze a solution that has already been thawed. GenXXLGear ships MOTS-c 10 mg with U.S. domestic and international options, and every batch carries a Certificate of Analysis from third-party HPLC testing.
Be the first to share your experience with Dragon Pharma MOTS-c 10 mg - Mitochondrial Peptide Vial
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
U.S Domestic
Available Domestic